-68% Off

Resof Total 400mg/100mg Tablet

Original price was: ₹18,046.88.Current price is: ₹5,700.00.

Resof Total 400mg/100mg Tablet serves as a combined antiviral medication. It helps treat cases of hepatitis C.

Product Details

Salt/Formula: Sofosbuvir (400mg) + Velpatasvir (100mg)

Manufacturer: Dr Reddy's Laboratories Ltd

Dosage: 400+100mg

Doctor's Prescription Required for this Product.
WhatsApp Enquiry Compare
Weight/Quantity: 28 tablets in 1 bottle

Store below 30°C

Benefits

Hepatitis C turns out to be a serious liver infection. It comes from the hepatitis C virus, often called HCV.

When the infection sticks around for months or even years, that leads to chronic hepatitis C.

The Resof Total 400mg/100mg Tablet works by cutting down the virus levels. It does this through blocking the way the virus spreads inside the body.

This treatment really helps in managing the infection better. It also aids the body in recovering more quickly from the effects.

You have to follow your doctor’s exact instructions when taking this medication.

How to use

Take this medicine exactly in the dose and duration prescribed by your doctor. Do not skip doses or stop the treatment without medical advice.

Specification

Take this medicine exactly in the dose and duration prescribed by your doctor. Do not skip doses or stop the treatment without medical advice.

Side Effects

A lot of side effects turn out to be mild. They often clear up once your body gets adjusted to the medication.

You need to check with your doctor.

Do that if side effects keep going or if they bother you in any way.

Resof Total comes with some common side effects.

Those include headache and tiredness.

Description

The Resof Total 400mg/100mg Tablet serves as a combined antiviral medication. It targets chronic hepatitis C, known as HCV, by battling the virus directly. In the end, this helps clear out the infection over time.

Reviews

There are no reviews yet.

Be the first to review “Resof Total 400mg/100mg Tablet”

Your email address will not be published. Required fields are marked *